- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05575141
Robotic Versus Open Comparison in the Surgical Treatment of Wide Abdominal Wall heRnias (ROCSTAR) (ROCSTAR)
April 10, 2025 updated by: Filip Muysoms, Algemeen Ziekenhuis Maria Middelares
Robotic Versus Open Comparison in the Surgical Treatment of Wide Abdominal Wall Hernias: a Multicenter International Randomized Controlled Trial
In the treatment of ventral incisional hernias, a mesh repair in the retromuscular plane is considered as the gold standard.
To allow for adequate medialization of the fascial borders and a complete closure of the defect in case of large incisional hernias, component separation techniques are increasingly being used.
When compared to anterior component separation, posterior component separation by transversus abdominis release (TAR) seems to decrease postoperative wound problems.
While laparoscopic techniques pose significant difficulties to perform TAR minimally invasively (mainly due to ergonomic and technical reasons), these limitations seem to be overcome by robotic platforms.
Initial retrospective patient series report on significantly shorter postoperative hospital stay and fewer complications after robotic transversus abdominis release (rTAR), when compared to open transversus abdominis release (oTAR).
High-quality prospective evidence on rTAR is currently lacking.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Maaike Vierstraete, MD
- Phone Number: +3293329500
- Email: maaikevierstraete@icloud.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- All patients requiring treatment of a wide ventral incisional hernia (of more than 8 centimetres in width)
Exclusion Criteria:
- Pregnant or suspected pregnancy
- Not-curatively treated malignancy, with life expectancy less than 24 months
- Patients unable to give informed consent or complete study specific questionnaires
- Emergency surgery
- Primary ventral hernia repair
- Exclusively lateral hernias not involving the midline
- Incisional hernia repair after open abdomen or enterocutaneous fistula
- Active wound infection
- Previous anterior or posterior component separation
- Patients with an existing ostomy
- Patients with a life expectancy of less than 24 months
- Patients suspected of being unable to comply with the study protocol
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: rTAR
Patients randomized in the robotic group will undergo the technique for intra-and perioperative management for robotic complex abdominal wall repair cases as used in the center.
A robotic surgical platform (da Vinci X or da Vinci Xi Surgical System, Intuitive Surgical, Aubonne, Switzerland) will be used and a retrorectus +/- retromuscular mesh placement performed.
Use of component separation or not will be at the discretion of the surgeon.
In principle the posterior layer and the anterior fascia will be closed avoiding a bridging technique.
Drain management and mesh fixation are left to the surgeon's preference.
|
Incisional hernia repair for the treatment of wide ventral incisional hernias.
|
|
Active Comparator: oTAR
Patients randomized in the open group will undergo the technique for intra-and perioperative management for open complex abdominal wall repair cases as used in the center.
A retrorectus +/- retromuscular mesh placement performed.
Use of component separation or not will be at the discretion of the surgeon.
In principle the posterior layer and the anterior fascia will be closed avoiding a bridging technique.
Drain management and mesh fixation are left to the surgeon's preference.
|
Incisional hernia repair for the treatment of wide ventral incisional hernias.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Length of postoperative hospital stay
Time Frame: hours from the end of surgery (last skin suture) until discharge, assessed up to 20 days
|
Length of postoperative hospital stay
|
hours from the end of surgery (last skin suture) until discharge, assessed up to 20 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reoperation rate
Time Frame: 30 days
|
Reoperation rate
|
30 days
|
|
Skin-to-skin operative time
Time Frame: Per-operative (minutes)
|
Skin-to-skin operative time from first incision until last skin suture
|
Per-operative (minutes)
|
|
Conversion rate
Time Frame: Per-operative
|
Conversion rate from the robotic-assisted approach to the open approach
|
Per-operative
|
|
Surgical site related complications
Time Frame: 30 days
|
Surgical site infection - surgical site occurrence - surgical site occurrence requiring procedural interventions
|
30 days
|
|
Readmission rate
Time Frame: 30 Days and 3 months postoperative
|
Readmission rate
|
30 Days and 3 months postoperative
|
|
Post-anesthetic discharge scoring system
Time Frame: From the end of surgery (last skin suture) until discharge, assessed up to 20 days
|
Minimum score is 0, maximum score is 12.
The higher the score, the better the outcome.
|
From the end of surgery (last skin suture) until discharge, assessed up to 20 days
|
|
Postoperative visual analogue scale pain score
Time Frame: From the end of surgery (last skin suture) until discharge, assessed up to 20 days
|
Minimum score is 0, maximum score is 10.
The higher the score, the worse the outcome.
|
From the end of surgery (last skin suture) until discharge, assessed up to 20 days
|
|
EuraHS Quality of Life Scoring
Time Frame: Preoperatively, 30 days, 3 months, 12 months, 24 months, 60 months
|
Minimum score is 0, maximum score is 90.
The higher the score, the worse the outcome.
|
Preoperatively, 30 days, 3 months, 12 months, 24 months, 60 months
|
|
Body Image Scale
Time Frame: Preoperatively, 30 days, 3 months, 12 months, 24 months, 60 months
|
Minimum score is 0, maximum score is 10.
A higher score means a higher level of body image disturbance (worse outcome).
|
Preoperatively, 30 days, 3 months, 12 months, 24 months, 60 months
|
|
Hernia recurrence
Time Frame: 30 days, 3 Months, 12 months, 24 months, 60 months
|
Hernia recurrence
|
30 days, 3 Months, 12 months, 24 months, 60 months
|
|
Reoperation for hernia recurrence or abdominal surgery not for hernia recurrence
Time Frame: 30 days, 3 Months, 12 months, 24 months, 60 months
|
Reoperation for hernia recurrence or abdominal surgery not for hernia recurrence
|
30 days, 3 Months, 12 months, 24 months, 60 months
|
|
Postoperative complications
Time Frame: 30 days
|
Postoperative complications classified acoording to the Clavien-Dindo Classification
|
30 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Filip Muysoms, MD PhD, Clinical research center Maria Middelares
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
July 1, 2025
Primary Completion (Estimated)
January 1, 2028
Study Completion (Estimated)
January 1, 2033
Study Registration Dates
First Submitted
April 2, 2022
First Submitted That Met QC Criteria
October 8, 2022
First Posted (Actual)
October 12, 2022
Study Record Updates
Last Update Posted (Actual)
April 11, 2025
Last Update Submitted That Met QC Criteria
April 10, 2025
Last Verified
April 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ROCSTAR
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Abdominal Wall Hernia
-
University of Sao Paulo General HospitalCompletedAbdominal Wall Defect | Infection | Abdominal Wall Hernia | Abdominal Wall Fistula | Abdominal Wall InfectionBrazil
-
Musculoskeletal Transplant FoundationWashington University School of Medicine; Pines Surgical; Meridian Healthcare...CompletedHernia of Abdominal WallUnited States
-
Meccellis BiotechActive, not recruitingAbdominal Hernia | Abdominal Wall Defect | Abdominal Wall InjuryFrance
-
Henares University HospitalCompletedHernia | Abdominal Wall Defect | Incisional Hernia | Abdominal Wall HerniaSpain
-
Lawson Health Research InstituteEthicon, Inc.Not yet recruitingIncisional Hernia of Anterior Abdominal Wall
-
Bispebjerg HospitalUniversity of CopenhagenCompletedRecurrent Hernia of Anterior Abdominal Wall
-
Institute for Clinical and Experimental MedicineNot yet recruitingAbdominal Wall Hernia
-
Duke UniversityLinda Cendales, MD; Kadiyala Ravindra, M.D.; Detlev Erdmann, M.D.RecruitingAbdominal Wall Defect | Abdominal Wall Hernia | Transplant; Failure, Liver | Transplant;Failure,Kidney | Transplant; Failure, Bowel | Abdominal Wall Fistula | Abdominal Wall InjuryUnited States
-
Ajou University School of MedicineCompletedHernia Abdominal WallKorea, Republic of
-
Bo LiRecruitingAbdominal Wall HerniaChina
Clinical Trials on incisional hernia repair
-
Clayton PetroRecruiting
-
Erasmus Medical CenterCompletedRecurrence | Postoperative Pain | Complications
-
US Department of Veterans AffairsCompletedHernia, VentralUnited States
-
Skane University HospitalLund University; Ethicon, Inc.; Crafoord Foundation; Region Skåne FoUU; The Einar... and other collaboratorsCompletedHERNIA, VENTRALSweden
-
Klinikum FuldaJohnson & JohnsonCompleted
-
Waitemata District Health BoardCompleted
-
University of Roma La SapienzaUnknownVentral Hernia | Incisional HerniaItaly
-
Hospices Civils de LyonRecruiting
-
Assistance Publique - Hôpitaux de ParisTerminatedIncisional Hernia | Umbilical HerniaFrance